Lymphatic filariasis is rare in the United States. DEC is no longer approved by the FDA, and providers will need CDC assistance with obtaining appropriate medications and also with the confirmation of infection.Â Patients with a coinfection of onchocerciasis with high levels of microfilaria should have a tropical medicine consultation.